Peter M. Henson, MD, PhD, BVMS

Peter M. Henson
Peter M. Henson, MD, is a researcher at National Jewish Health. Dr. Henson is in the Division of Cell Biology and Department of Pediatrics.
Professor
Department of Immunology and Genomic Medicine
Department of Pediatrics
Division of Cell Biology
image descriptionPrograms & Services
Research AreasResearch Areas
  • Basic Immunology
  • Cellular and Molecular Biology
  • Inflammation
  • Lung Cell Biology
  • Mycobacterial and Respiratory Infections
  • Pathology
  • Pulmonary Medicine
  • Regenerative Medicine
  • Allergy

Special Interests

Innate immunity, experimental pathology, Inflammation and inflammmatory respiratory diseases

Education

Education
University of Cambridge, PhD
University of Edinburgh, BSc with Honors, Microbiology
University of Edinburgh, BVM&S
Fellowship
Scripps Research Institute, Experimental Pathology

Awards & Recognition

2011: Distinguished Professorship, University of Colorado
2005: Burns Amberson Lecture, ATS Centenary Meeting
1991: Margaret A. Regan Professor of Pulmonary Inflammation
1983: Reticuloendothelial Society, Marie T. Bonazinga Award
1980:American Association of Pathologists, Parke Davis Award

Publications

Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL and Henson PM. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol. 148(7):2207-2216, 1992.

Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGFβ, PGE2, and PAF. J. Clin. Invest. 101:890-898, 1998.  Huynh, M-LN, Fadok VA, Henson PM. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGFβ1 secretion and resolution of inflammation. J Clin Invest 109:41-50, 2002.

Gardai S.J, McPhillips KA, Frasch SC, Janssen W.J, Starefeldt A, Murphy-Ullrich JE, Bratton DL, Oldenborg PA, Michalak M, Henson PM. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 123:321-334, 2005.

Gardai SJ, Xiao Y-Q, Dickinson M, Nick J, Voelker D, Greene K, Henson P. By binding SIRPα or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell. 115:13-23, 2003.

Desch AN, Gibbings SL, Clambey ET, Janssen WJ, Slansky JE, Kedl RM, Henson PM, and Jakubzick C. Dendritic cell subsets require cis-activation for cytotoxic CD8 T-cell induction. Nature communications, 5:4674 2014.

Academic Affiliations

Professor, Departments of Immunology and Microbiology, Medicine, Pharmacology, University of Colorado Denver

 

Teaching & Professional Positions

Associate Director, Pulmonary and Critical Care Fellowship Program
Member, Immunology Graduate Program Steering Committee

Ask a Question through MyChart

Sign in to your MyChart account to communicate with your care team, manage appointments, and more. Create an Account
 

Contact Information

  • Office: 877.225.5654
  • Fax: 303.398.1381

Patient Ratings

The Patient Rating score is an average of all responses to care provider related questions on our independent rating system, the Press Ganey Patient Satisfaction Survey. This survey is about the patient care experience and does not address crucial characteristics like medical decision-making, prescribing the best therapy, and patient outcomes.

Responses are measured on a scale of 1 to 5, with 5 being the best score. Learn more about our patient satisfaction survey.
 
 

Comments

Comments are collected in our Press Ganey Patient Satisfaction Surveys. Patients are de-identified to protect confidentiality and patient privacy. Learn more about our patient satisfaction survey.